AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
2.090
-0.140 (-6.28%)
At close: Apr 1, 2025, 4:00 PM
2.190
+0.100 (4.78%)
After-hours: Apr 1, 2025, 7:57 PM EDT

AbCellera Biologics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Cash & Equivalents
156.33133.32386.54476.14594.12
Upgrade
Short-Term Investments
469.29627.27499.95246.84-
Upgrade
Cash & Short-Term Investments
625.61760.59886.49722.98594.12
Upgrade
Cash Growth
-17.75%-14.20%22.62%21.69%7765.96%
Upgrade
Accounts Receivable
33.6230.5938.59160.58213.24
Upgrade
Other Receivables
26.5333.7964.8214.280.49
Upgrade
Receivables
92.1364.38103.41174.86213.73
Upgrade
Inventory
--1.531.671.41
Upgrade
Prepaid Expenses
8.6322.029.065.294.07
Upgrade
Restricted Cash
25252525-
Upgrade
Total Current Assets
751.37871.991,025929.8813.33
Upgrade
Property, Plant & Equipment
340.43287.7217.26111.6217.92
Upgrade
Long-Term Investments
82.365.9434.4232.3120.03
Upgrade
Goodwill
47.8147.8147.8147.8131.5
Upgrade
Other Intangible Assets
42.11120.43131.5148.39115.15
Upgrade
Long-Term Deferred Tax Assets
----5.9
Upgrade
Other Long-Term Assets
66.9480.3440.8330.641.71
Upgrade
Total Assets
1,3611,4881,5411,3191,006
Upgrade
Accounts Payable
34.3528.614.8314.927.32
Upgrade
Accrued Expenses
8.387.7125.826.5429.13
Upgrade
Current Portion of Leases
4.626.165.583.650.68
Upgrade
Current Income Taxes Payable
---35.6836.15
Upgrade
Current Unearned Revenue
21.1826.0727.912.017.53
Upgrade
Other Current Liabilities
8.0950.4844.2127.8722.68
Upgrade
Total Current Liabilities
76.61119.01118.32120.68103.49
Upgrade
Long-Term Leases
60.7471.2276.6836.413.72
Upgrade
Long-Term Unearned Revenue
155.59104.1160.3260.7625.89
Upgrade
Long-Term Deferred Tax Liabilities
10.0530.6133.1837.3726.16
Upgrade
Other Long-Term Liabilities
1.4710.8219.1437.6215.77
Upgrade
Total Liabilities
304.47335.78307.63292.84175.03
Upgrade
Common Stock
777.17753.2734.37722.43710.39
Upgrade
Additional Paid-In Capital
166.36121.0574.1235.365.92
Upgrade
Retained Earnings
116.93279.79426.19267.67114.2
Upgrade
Comprehensive Income & Other
-4.38-1.72-1.390.28-
Upgrade
Total Common Equity
1,0561,1521,2331,026830.51
Upgrade
Shareholders' Equity
1,0561,1521,2331,026830.51
Upgrade
Total Liabilities & Equity
1,3611,4881,5411,3191,006
Upgrade
Total Debt
65.3677.3882.2640.074.39
Upgrade
Net Cash (Debt)
560.25683.21804.23682.91589.73
Upgrade
Net Cash Growth
-18.00%-15.05%17.76%15.80%88982.48%
Upgrade
Net Cash Per Share
1.902.362.552.152.24
Upgrade
Filing Date Shares Outstanding
297.99292.78287.69283.92269.5
Upgrade
Total Common Shares Outstanding
295.76290.82286.85283.26269.5
Upgrade
Working Capital
674.76752.97907.17809.12709.84
Upgrade
Book Value Per Share
3.573.964.303.623.08
Upgrade
Tangible Book Value
966.17984.091,054829.54683.86
Upgrade
Tangible Book Value Per Share
3.273.383.672.932.54
Upgrade
Land
53.4153.4153.4133.04-
Upgrade
Buildings
52.9143.9511.361.21-
Upgrade
Machinery
84.2973.8749.5626.6515.87
Upgrade
Leasehold Improvements
122.8973.9440.5722.753.71
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q